5 Steps to prevent Heart Disease

Friday, July 31, 2015

4 new drugs for long term treatment of chronic obesity.




If there is an epidemic of obesity why are you not treating it?  LINK above


As a Diplomat of the American Board of Obesity Medicine and a Fellow and Diplomat in the National Lipid Association  I think you should consider putting your obese patients on one of the following diet pills for the chronic disease of obesity on a long term basis:

1- Lorcaserin (BELVIQ)

2- Phentermine/Topiramate (QSYMIA)

3- Liraglutide (SAXENDA)

4- Naltrexone/Bupropion (CONTRAVE)



My personal experience with Victoza, Invokana and Qsymia link

Update 12-13-15 Post ABOM exam:

 

Let me give some ideas as to how to choose which drug, which should be done in concert with your physician. 



Diet meds usually indicated if BMI >26 + comorbidity or > 30.

First step.
If fast glucose >99 go on Metformin. 

Second step. 
If diabetic already on maximum dose metformin add Victoza as this Liraglutamide will be paid for .  

Third step
If on Insulin try switching over to Invokana.  Careful monitoring of glucose during transition and suggest switching to Atkins or LCHF.

Now for the Diet medicines themselves. 

First choice?
LOCASERIN (Belviq)
Why?
May be  safest drug.
Young women are less of a concern than with Qsymia. 
Caution with depressed patients.
There is a concern for serotonin syndrome but to my knowledge this drug does not increase serotonin levels. 
Downside: Only 50% have good response. 

Solution: After two or three months add Phentermine one half tab 37.5 mg a day if no cardiac or anxiety contraindications. This is generic drug now. This addition is off label for long term despite the combination in Qsymia having the indication for long term.

Second choice?
PHENTERMINE/TOPIRAMATE (Qsymia)
Main concern: REMS caution for pregnancy testing.
Good point: Can give to depressed patients.
Side-effects: high dose can cause cognition problems
dysgeusia especially with diet soda. 
Potentiates alcohol.
Metabolic acidosis, decrease potassium, increase Creatinine. 
 Consider getting chemistry level after first month of treatment.

Third Choice?
NALTREXONE/BUPROPION/CONTRAVE
Best news: Non-scheduled drug
Bad news: Label legacy
These 2 drugs have been around for some long that many side effects have shown up on the PDR over the years. 
BLACK BOX WARNING: Depression and Neuro-psych disorders
Do not give to people on narcotic pain medicine. 
Careful in people prone to seizures.  
Thus in young folks who might binge on alcohol this might not be the first choice. 
Not for bulemia or anorexia nervosa 
Don't take with Levadopa or Amantadine
UPDATE: Still some concerns about increase HTN?

Four Choice?
LIRAGLUTAMIDE (Saxenda)
Expensive and an injection.
If diabetic can get lower dose paid for as Victoza. 
BLACK BOX WARNING: Thyroid C cell tumors
Side effects: vomiting, pancreatitis, abdominal pain
Good news: Non-scheduled drug 

Frank Greenway Recent of Obesity Medicine link

"Following gastric bypass surgery, levels of ghrelin are extremely low,39 while GLP-1 and PYY are elevated,46 which should attenuate appetite."

"However, recent studies in rodents have indicated that weight loss following sleeve gastrectomy is not mediated by changes in ghrelin or GLP-1, or through the melanocortin (MC)-4 receptor in the hypothalamus.47, 48, 49 Instead, as shown by a knockout mouse study, the mechanism of weight loss in sleeve gastrectomy appears to involve the nuclear bile acid receptor, farnesoid X receptor.50
Note that the observation that gut hormones such as ghrelin and GLP-1 are not involved in the mechanism of weight loss with sleeve gastrectomy does not mean that they are not important mediators of body weight."

Choosing which weight lost surgery is best for a patient is not based on random controlled head to head trials.  Lap band by experience has lost favor. 

The surgeons are allowed this freedom to discover the best course for the obese patients. 

Likewise, ABOM specialists will treat "off label" the multiple pathways that cause weight regain with multiple drugs. 

 
 






  




  


No comments:

Post a Comment